ARTICLE | Clinical News
PH-10 radiosensitizer regulatory update
December 24, 2001 8:00 AM UTC
PHGN received U.S. Patent No. 6,331,286 covering the use of PH-10 as a radiosensitizer to enhance therapeutic effects and diminish side effects of radiation therapy. Topical PH-10 is in Phase I testin...